These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 18386634)

  • 1. [Relationship between cardiac 123I-metaiodobenzylguanidine scintigraphy and cardiovascular autonomic function test (standing test) in Parkinson's disease].
    Doi H; Niimi Y; Hasegawa Y; Miwa S; Yamana T; Takagi S; Takahashi A; Sobue G
    Rinsho Shinkeigaku; 2008 Jan; 48(1):56-9. PubMed ID: 18386634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cardiac sympathetic dysfunction in Parkinson's disease--relationship between results of 123I-MIBG scintigraphy and autonomic nervous function evaluated by the Valsalva maneuver].
    Oka H; Yoshioka M; Morita M; Mochio S; Inoue K
    Rinsho Shinkeigaku; 2003 Aug; 43(8):465-9. PubMed ID: 14658397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease.
    Orimo S; Ozawa E; Nakade S; Sugimoto T; Mizusawa H
    J Neurol Neurosurg Psychiatry; 1999 Aug; 67(2):189-94. PubMed ID: 10406987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Iodine 123-labeled meta-iodobenzylguanidine myocardial scintigraphy in the cases of idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy].
    Yoshita M; Hayashi M; Hirai S
    Rinsho Shinkeigaku; 1997 Jun; 37(6):476-82. PubMed ID: 9366173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [123 I-MIBG myocardial sympathetic innervation scintigraphy and Parkinson's disease. Preliminary results].
    Jiménez-Hoyuela JM; Rebollo AC; Campos V; Rius F
    Rev Esp Med Nucl; 2003; 22(4):229-37. PubMed ID: 12846947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac sympathetic denervation from the early stage of Parkinson's disease: clinical and experimental studies with radiolabeled MIBG.
    Takatsu H; Nishida H; Matsuo H; Watanabe S; Nagashima K; Wada H; Noda T; Nishigaki K; Fujiwara H
    J Nucl Med; 2000 Jan; 41(1):71-7. PubMed ID: 10647607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of 123I-MIBG uptake by the heart in Parkinson's disease: assessment of cardiac sympathetic denervation and diagnostic value.
    Satoh A; Serita T; Seto M; Tomita I; Satoh H; Iwanaga K; Takashima H; Tsujihata M
    J Nucl Med; 1999 Mar; 40(3):371-5. PubMed ID: 10086697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Early alteration of adrenergic cardiac function in parkinsonisms with Lewy bodies].
    Jiménez-Hoyuela García JM; Campos Arillo V; Rebollo Aguirre AC; Gómez Doblas JJ; Gutiérrez Hurtado A
    Rev Esp Med Nucl; 2005; 24(2):93-100. PubMed ID: 15745679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac 123I-MIBG reflects left ventricular functional reserve in patients with nonobstructive hypertrophic cardiomyopathy.
    Isobe S; Izawa H; Iwase M; Nanasato M; Nonokawa M; Ando A; Ohshima S; Nagata K; Kato K; Nishizawa T; Murohara T; Yokota M
    J Nucl Med; 2005 Jun; 46(6):909-16. PubMed ID: 15937299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the relationship between muscle sympathetic nerve activity and cardiac 123I-metaiodobenzylguanidine uptake in patients with Parkinson's disease.
    Shindo K; Kaneko E; Watanabe H; Sugimoto T; Ohta E; Ohashi K; Nagasaka T; Shiozawa Z
    Mov Disord; 2005 Nov; 20(11):1419-24. PubMed ID: 16007621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired cardiac uptake of meta-[123I]iodobenzylguanidine in Parkinson's disease with autonomic failure.
    Braune S; Reinhardt M; Bathmann J; Krause T; Lehmann M; Lücking CH
    Acta Neurol Scand; 1998 May; 97(5):307-14. PubMed ID: 9613560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired myocardial 123I-metaiodobenzylguanidine uptake in Lewy body disease: comparison between dementia with Lewy bodies and Parkinson's disease.
    Suzuki M; Kurita A; Hashimoto M; Fukumitsu N; Abo M; Ito Y; Urashima M; Inoue K
    J Neurol Sci; 2006 Jan; 240(1-2):15-9. PubMed ID: 16199056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies].
    Orimo S
    Rinsho Shinkeigaku; 2008 Jan; 48(1):11-24. PubMed ID: 18386627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac uptake of [123I]MIBG separates Parkinson's disease from multiple system atrophy.
    Braune S; Reinhardt M; Schnitzer R; Riedel A; Lücking CH
    Neurology; 1999 Sep; 53(5):1020-5. PubMed ID: 10496261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormalities of cardiac sympathetic function in pacing-induced heart failure as assessed by [123I]metaiodobenzylguanidine scintigraphy.
    Simmons WW; Freeman MR; Grima EA; Hsia TW; Armstrong PW
    Circulation; 1994 Jun; 89(6):2843-51. PubMed ID: 8205700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical relationship of myocardial sympathetic nervous activity to cardiovascular functions in chronic heart failure: assessment by myocardial scintigraphy with 123I-metaiodobenzylguanidine.
    Wada Y; Miura M; Fujiwara S; Mori S; Seiji K; Kimura T
    Tohoku J Exp Med; 2003 Dec; 201(4):261-70. PubMed ID: 14690018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Early alterations of adrenergic cardiac function in Parkinson's disease].
    Campos V; Rebollo AC; Jiménez-Hoyuela JM; Gómez-Doblas JJ; Medialdea P; Vila E; Gutiérrez-Hurtado A
    Neurologia; 2004 Mar; 19(2):53-8. PubMed ID: 14986180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential imaging analysis using MIBG scintigraphy revealed progressive degeneration of cardiac sympathetic nerve in Parkinson's disease.
    Watanabe M; Takeda T; Nakamagoe K; Tamaoka A
    Eur J Neurol; 2011 Jul; 18(7):1010-3. PubMed ID: 21658161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathology of the sympathetic nervous system corresponding to the decreased cardiac uptake in 123I-metaiodobenzylguanidine (MIBG) scintigraphy in a patient with Parkinson disease.
    Mitsui J; Saito Y; Momose T; Shimizu J; Arai N; Shibahara J; Ugawa Y; Kanazawa I; Tsuji S; Murayama S
    J Neurol Sci; 2006 Apr; 243(1-2):101-4. PubMed ID: 16442563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between plasma norepinephrine at peak exercise and 123I-MIBG imaging of the heart and lower limbs in heart failure.
    Tsuchida T; Fukuma N; Oikawa K; Kato K; Kato Y; Takano T; Kumita S
    J Nippon Med Sch; 2007 Apr; 74(2):114-22. PubMed ID: 17507788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.